Hypotension during Septic Shock Does Not Correlate with Plasma Levels of Nitric Oxide Metabolites in the Conscious Rat

被引:14
作者
Klemm K. [1 ]
Mercer D.W. [1 ,3 ]
Mailman D. [2 ]
Moody F.G. [1 ]
机构
[1] Department of Surgery, University of Houston, Houston, TX
[2] University of Texas, Houston Medical School, University of Houston, Houston, TX
[3] University of Texas, Houston Medical School, MSB 4.286, 6431 Fannin, Houston
基金
美国国家卫生研究院;
关键词
Nitric Oxide; Septic Shock; Arterial Blood Pressure; Endotoxic Shock; Nitric Oxide Metabolite;
D O I
10.1016/S1091-255X(97)80056-X
中图分类号
学科分类号
摘要
Hypotension following administration of lipopolysaccharide may be due to excessive production of the potent vasodilator nitric oxide brought about by induction of nitric oxide synthase. The purpose of this study was to determine in conscious, fasted rats what role nitric oxide played in lipopolysaccharide-induced hypotension. When examined by Western immunoblot analysis, inducible nitric oxide synthase immunoreactivity was detected in the aorta at 3 hours and increased over time following administration of intraperitoneal lipopolysaccharide (20 mg/kg). When compared with saline-treated control rats, significant hypotension was observed at 2, 4, and 6 hours following lipopolysaccharide treatment. Blood pressure at 2 hours did not differ significantly from that at 6 hours. Using the Griess reaction to quantify plasma levels of nitrates and nitrites as an index of systemic nitric oxide production, an augmentation in the formation of these nitric oxide metabolites was demonstrated at 4 and 6 hours but not at 2 hours. Subcutaneous administration of the nitric oxide synthase inhibitor NG-nitro-L-arginine methyl ester (5 mg/kg) prevented lipopolysaccharide-induced hypotension, an effect reversed by subcutaneous L-arginine but not D-arginine (350 mg/kg). However, nitric oxide synthase inhibition did not attenuate the ability of lipopolysaccharide to increase plasma nitrate/nitrite levels. These data indicate that lipopolysaccharide-induced production of nitric oxide metabolites does not correlate with lipopolysaccharide-induced hypotension.
引用
收藏
页码:347 / 356
页数:9
相关论文
共 27 条
[1]  
Moncada, S., Palmer, R.M.J., Higgs, E.A., Nitric oxide: Physiology, pathophysiology, and pharmacology (1991) Pharm Rev, 43, pp. 109-142
[2]  
Kuo, P.C., Schroeder, R.A., The emerging multifaceted roles of nitric oxide (1995) Ann Surg, 221, pp. 220-235
[3]  
Nathan, C., Nitric oxide as a secretory product of mammalian cells (1992) FASEBJ, 6, pp. 3051-3064
[4]  
Moncada, S., Higgs, A., The L-arginine-nitric oxide pathway (1993) N Engl J Med, 329, pp. 2002-2012
[5]  
Stuehr, D.J., Marletta, M.A., Mammalian nitrate biosynthesis: Mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide (1985) Proc Nad Acad Sci USA, 82, pp. 7738-7742
[6]  
Ochoa, J.B., Udekwu, A.O., Billiar, T.R., Curran, R.D., Cerra, F.B., Simons, R.L., Peitzman, A.B., Nitrogen oxide levels in patients after trauma and during sepsis (1991) Ann Surg, 214, pp. 621-626
[7]  
Nava, E., Palmer, R.M.J., Moncada, S., The role of nitric oxide in endotoxic shock: Effects of NG-monomethyl-L-arginine (1992) J Cardiovasc Pharmacol, 20 (12 SUPPL.), pp. S132-S134
[8]  
Van Den Berg, C., Van Amsterdam, J.G.C., Bisschop, A., Piet, J.J., Wemer, J., De Wildt, D.J., Septic shock: Nitric oxide correlation between plasma levels of nitric oxide metabolites and hypotension or lethality (1994) Eur J Pharmacol, 270, pp. 379-382
[9]  
Kilbourn, R.G., Jubran, A., Gross, S.S., Griffith, O.W., Levi, R., Adams, J., Lodato, R.F., Reversal of endotoxin-mediated shock by NG-methyl-L-arginine, an inhibitor of nitric oxide synthesis (1990) Biochem Biophys Res Commun, 172, pp. 1131-1138
[10]  
Petros, A., Bennett, D., Vallance, P., Effect of nitric oxide synthase inhibitors on hypotension in patients with sepsis (1991) Lancet, 338, pp. 1557-1558